Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Literature DB >> 26679628

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Peter G Pappas¹, Carol A Kauffman², David R Andes³, Cornelius J Clancy⁴, Kieren A Marr⁵, Luis Ostrosky-Zeichner⁶, Annette C Reboli⁷, Mindy G Schuster⁸, Jose A Vazquez⁹, Thomas J Walsh¹⁰, Theoklis E Zaoutis¹¹, Jack D Sobel¹².

Abstract

It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. IDSA considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances.

Entities: Disease Species

Keywords: azoles; candidemia; echinocandins; fungal diagnostics; invasive candidiasis

Mesh：

Substances：
Antifungal Agents

Year: 2015 PMID： 26679628 PMCID： PMC4725385 DOI： 10.1093/cid/civ933

Source DB: PubMed Journal: Clin Infect Dis ISSN： 1058-4838 Impact factor: 9.079

551 in total

Review 1. Candidal meningitis in HIV-infected patients: analysis of 14 cases.

Authors: J L Casado; C Quereda; J Oliva; E Navas; A Moreno; V Pintado; J Cobo; I Corral
Journal: Clin Infect Dis Date: 1997-09 Impact factor: 9.079

2. Candida endocarditis in neonates: report of five cases and review of the literature.

Authors: Itzhak Levy; Itamar Shalit; Einat Birk; Lea Sirota; Shai Ashkenazi; Baruch German; Nehama Linder
Journal: Mycoses Date: 2006-01 Impact factor: 4.377

Review 3. New insights into hepatosplenic candidosis, a manifestation of chronic disseminated candidosis.

Authors: B Rammaert; A Desjardins; O Lortholary
Journal: Mycoses Date: 2012-02-24 Impact factor: 4.377

4. Refractory candidal meningitis in an immunocompromised patient cured by caspofungin.

Authors: Kung-Hung Liu; Chi-Jung Wu; Chen-Hsi Chou; Hsin-Chun Lee; Nan-Yao Lee; Shao-Tsung Hung; Wen-Chien Ko
Journal: J Clin Microbiol Date: 2004-12 Impact factor: 5.948

5. Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit.

Authors: C Mary Healy; Carol J Baker; Elena Zaccaria; Judith R Campbell
Journal: J Pediatr Date: 2005-08 Impact factor: 4.406

6. Detection of candidaemia in patients with and without underlying haematological disease.

Authors: M C Arendrup; O J Bergmann; L Larsson; H V Nielsen; J O Jarløv; B Christensson
Journal: Clin Microbiol Infect Date: 2009-12-11 Impact factor: 8.067

7. Successful treatment of disseminated candidiasis resistant to amphotericin B by liposomal amphotericin B: a case report.

Authors: P C Gokhale; R J Barapatre; S H Advani; N A Kshirsagar; S K Pandya
Journal: J Cancer Res Clin Oncol Date: 1993 Impact factor: 4.553

8. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

Authors: Peter G Pappas; John H Rex; Jeannette Lee; Richard J Hamill; Robert A Larsen; William Powderly; Carol A Kauffman; Newton Hyslop; Julie E Mangino; Stanley Chapman; Harold W Horowitz; John E Edwards; William E Dismukes
Journal: Clin Infect Dis Date: 2003-08-14 Impact factor: 9.079

9. A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

Authors: John H Rex; Peter G Pappas; Adolf W Karchmer; Jack Sobel; John E Edwards; Susan Hadley; Corstiaan Brass; Jose A Vazquez; Stanley W Chapman; Harold W Horowitz; Marcus Zervos; David McKinsey; Jeannette Lee; Timothy Babinchak; Robert W Bradsher; John D Cleary; David M Cohen; Larry Danziger; Mitchell Goldman; Jesse Goodman; Eileen Hilton; Newton E Hyslop; Daniel H Kett; Jon Lutz; Robert H Rubin; W Michael Scheld; Mindy Schuster; Bryan Simmons; David K Stein; Ronald G Washburn; Linda Mautner; Teng-Chiao Chu; Helene Panzer; Rebecca B Rosenstein; Jenia Booth
Journal: Clin Infect Dis Date: 2003-05-08 Impact factor: 9.079

10. Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy.

Authors: E Anaissie; G P Bodey; H Kantarjian; C David; K Barnett; E Bow; R Defelice; N Downs; T File; G Karam
Journal: Am J Med Date: 1991-08 Impact factor: 4.965

746 in total

1. Pharmacokinetics of Caspofungin in Critically Ill Patients in Relation to Liver Dysfunction: Differential Impact of Plasma Albumin and Bilirubin Levels.

Authors: S Kurland; M Furebring; E Löwdin; E Eliasson; E I Nielsen; J Sjölin
Journal: Antimicrob Agents Chemother Date: 2019-05-24 Impact factor: 5.191

2. Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015-2017.

Authors: Lindsey M Weiner-Lastinger; Sheila Abner; Jonathan R Edwards; Alexander J Kallen; Maria Karlsson; Shelley S Magill; Daniel Pollock; Isaac See; Minn M Soe; Maroya S Walters; Margaret A Dudeck
Journal: Infect Control Hosp Epidemiol Date: 2019-11-26 Impact factor: 3.254

3. Model-Optimized Fluconazole Dose Selection for Critically Ill Patients Improves Early Pharmacodynamic Target Attainment without the Need for Therapeutic Drug Monitoring.

Authors: Indy Sandaradura; Jessica Wojciechowski; Deborah J E Marriott; Richard O Day; Sophie Stocker; Stephanie E Reuter
Journal: Antimicrob Agents Chemother Date: 2021-02-17 Impact factor: 5.191

4. Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill Patients.

Authors: J M Boonstra; A G Märtson; I Sandaradura; J G W Kosterink; T S van der Werf; D J E Marriott; J G Zijlstra; D J Touw; J W C Alffenaar
Journal: Antimicrob Agents Chemother Date: 2021-02-17 Impact factor: 5.191

5. Transcription factor network efficiency in the regulation of Candida albicans biofilms: it is a small world.

Authors: Virginia E Glazier; Damian J Krysan
Journal: Curr Genet Date: 2018-01-09 Impact factor: 3.886

6. Population pharmacokinetics of fluconazole in liver transplantation: implications for target attainment for infections with Candida albicans and non-albicans spp.

Authors: Pier Giorgio Cojutti; Manuela Lugano; Elda Righi; Giorgio Della Rocca; Matteo Bassetti; William Hope; Federico Pea
Journal: Eur J Clin Pharmacol Date: 2018-07-21 Impact factor: 2.953

7. Management of candiduria in hospitalized patients: a single-center study on the implementation of IDSA guidelines and factors affecting clinical decisions.

Authors: Zhengxin He; Xiaosai Huo; Daxin Lei; Huihai Zhao; Keran Jia; Fukun Wang
Journal: Eur J Clin Microbiol Infect Dis Date: 2020-07-30 Impact factor: 3.267

8. The Effectiveness of Voriconazole in Therapy of Candida glabrata's Biofilms Oral Infections and Its Influence on the Matrix Composition and Gene Expression.

Authors: Célia F Rodrigues; Bruna Gonçalves; Maria Elisa Rodrigues; Sónia Silva; Joana Azeredo; Mariana Henriques
Journal: Mycopathologia Date: 2017-04-24 Impact factor: 2.574

9. High-Dose Micafungin for Preterm Neonates and Infants with Invasive and Central Nervous System Candidiasis.

Authors: Cinzia Auriti; Marco Falcone; Maria Paola Ronchetti; Bianca Maria Goffredo; Sara Cairoli; Rosamaria Crisafulli; Fiammetta Piersigilli; Tiziana Corsetti; Andrea Dotta; Manjunath P Pai
Journal: Antimicrob Agents Chemother Date: 2016-11-21 Impact factor: 5.191

10. Hot topics in antifungal susceptibility testing: A new drug, a bad bug, sweeping caspofungin testing under the rug, and solving the ECV shrug.

Authors: Shawn R Lockhart; Elizabeth L Berkow
Journal: Clin Microbiol Newsl Date: 2016-07